Icariin ameliorates LPS-induced acute lung injury in mice via complement C5a-C5aR1 and TLR4 signaling pathways
International Immunopharmacology · 2024-04 · 131 · 111802
DOI: 10.1016/j.intimp.2024.111802 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-04. Verfasst von Jing Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China; Natural Products Research …. Hauptthemen laut MEDLINE: Acute Lung Injury, Complement C5a, Flavonoids, Lipopolysaccharides. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Guizhou Provincial Natural Science Foundation, Guizhou Provincial Science and Technology Department, National Natural Science Foundation of China.
Abstract (Originalsprache)
Acute lung injury (ALI) is an acute respiratory-related progressive disorder, which lacks specific pharmacotherapy. Icariin (ICA) has been shown to be effective in treating ALI. However, the targets and pharmacological mechanisms underlying the effects of ICA in the treatment of ALI are relatively lacking. Based on network pharmacology and molecular docking analyses, the gene functions and potential target pathways of ICA in the treatment of ALI were determined. In addition, the underlying mechanisms of ICA were verified by immunohistochemistry, immunofluorescence, quantitative Real-time PCR, and Western blot in LPS-induced ALI mice. The biological processes targeted by ICA in the treatment of ALI included the pathological changes, inflammatory response, and cell signal transduction. Network pharmacology, molecular docking, and in vivo experimental results revealed that ICA inhibited the complement C5a-C5aR1 axis, TLR4 mediated NF-κB, MAPK, and JAK2-STAT3 signaling pathways related gene and protein expressions, and decreased inflammatory cytokine, chemokine, adhesion molecule expressions, and mitochondrial apoptosis in LPS-induced ALI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China; Natural Products Research Center of Guizhou Province, Guiyang 550014, China; School of Chinese E…
- State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China; Natural Products Research Center of Guizhou Province, Guiyang 550014, China.
- General Ward, Guizhou Provincial People's Hospital, Guiyang 550002, China. Electronic address: limin_67@hotmail.com.
- State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China; Natural Products Research Center of Guizhou Province, Guiyang 550014, China. Electronic address:…
Förderung
- Guizhou Provincial Natural Science Foundation
- Guizhou Provincial Science and Technology Department
- National Natural Science Foundation of China
- Guizhou Minzu University
Zitieren
APA
Guo, J., Zhang, Q. Y., Xu, L., Li, M., & Sun, Q. Y. (2024). Icariin ameliorates LPS-induced acute lung injury in mice via complement C5a-C5aR1 and TLR4 signaling pathways. International Immunopharmacology, 131, 111802. https://doi.org/10.1016/j.intimp.2024.111802
Vancouver
Guo J, Zhang QY, Xu L, Li M, Sun QY. Icariin ameliorates LPS-induced acute lung injury in mice via complement C5a-C5aR1 and TLR4 signaling pathways. International Immunopharmacology. 2024;131:111802. doi:10.1016/j.intimp.2024.111802
BibTeX
@article{Guo2024,
author = {Guo, Jing and Zhang, Qi-Yun and Xu, Lin and Li, Min and Sun, Qian-Yun},
title = {Icariin ameliorates LPS-induced acute lung injury in mice via complement C5a-C5aR1 and TLR4 signaling pathways},
journal = {International Immunopharmacology},
year = {2024},
volume = {131},
pages = {111802},
doi = {10.1016/j.intimp.2024.111802}
}
EUVIMED